A long-standing mystery about early cells has a solution—and it’s a rather magical one.
A New Clue to How Life Originated
Posted in futurism
Combating Antibiotic-Resistant Bacteria — Dr. Erin Duffy, Ph.D., Chief of Research & Development, and Kevin Outterson, ESQ., Executive Director, CARB-X.
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X — https://carb-x.org/) is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world. 1.27 million deaths worldwide were attributed to resistant bacterial infections in 2019.
The CARB-X portfolio is the world’s most scientifically diverse, early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products and represents the only global partnership that integrates solutions for the prevention, diagnosis and treatment of life-threatening bacterial infections, translating innovation from basic research to first-in-human clinical trials.
Targeting Root Causes Of Diseases And Aging — Dr. Andrew Adams, Ph.D., Vice President, Neurodegeneration Research; Co-Director, Lilly Institute for Genetic Medicine, Eli Lilly.
Dr. Andrew Adams, Ph.D. is Vice President of Neurodegeneration Research at Eli Lilly (https://www.lilly.com/) and Co-Director of their new Lilly Institute for Genetic Medicine (https://lilly.mediaroom.com/2022-02-22-Lilly-Announc…ort-Site), a $700 million initiative to establish an institute for researching and developing genetic medicines, specifically acting at the nucleic acid level, to advance an entirely new drug class that target the root cause of diseases, an approach that is fundamentally different than medicines available today.
In this role, Dr. Adams will be responsible for leading the discovery of various new types of therapies, via both internal research, and robust collaborations with external partners.
A lucky discovery involving lithium-sulfur batteries has a legitimate chance to revolutionize how we power our world.
The four Ax-1 astronauts will get to spend about 12 extra hours on the orbiting lab.
The first-ever fully private crewed mission to the International Space Station will get to spend 12 extra hours aboard the orbiting lab.
The four astronauts of Ax-1, a mission organized by Houston company Axiom Space, had been scheduled to depart the station in their SpaceX Dragon capsule at 10:35 a.m. EDT (1435 GMT) on Tuesday (April 19) and splash down off the coast of Florida early Wednesday morning (April 20).
SpaceXs brand-new Dragon spacecraft – named “Freedom” by the Crew-4 astronauts – arrived at Kennedy Space Center’s Launch Complex 39A on April 16, 2022, after making the journey from SpaceX’s processing facility at nearby Cape Canaveral Space Force Station in Florida. After Dragon is mated to the SpaceX Falcon 9 rocket, the launch vehicle will roll out to the pad and be raised to the vertical launch position.
Liftoff is scheduled for 5:26 a.m. EDT on Saturday, April 23. NASA’s Crew-4 mission is the fourth crew rotation flight on a SpaceX Dragon spacecraft and Falcon 9 rocket. NASA astronauts Kjell Lindgren and Bob Hines will serve as mission commander and pilot, respectively, and NASA astronaut Jessica Watkins and ESA (European Space Agency) astronaut Samantha Cristoforetti, will join as mission specialists.
If all goes according to plan, Jessica Watkins will become the first African-American woman to make a prolonged ISS stay.
Experiments on how anaesthetics alter the behaviour of tiny structures found in brain cells bolster the controversial idea that quantum effects in the brain might explain consciousness.
How we drained California dry
Posted in futurism
Deep learning–based language models, such as BERT, T5, XLNet and GPT, are promising for analyzing speech and texts. In recent years, however, they have also been applied in the fields of biomedicine and biotechnology to study genetic codes and proteins.